VMT01-T101 Phase 1/2a, First-in-human, Multicenter Dose Escalation and Dose Expansion Study of [203/212Pb] VMT01 Recepto-targeted, Image-guided Alpha-particle Therapy in Patients with Previously Treated unresectable or metastatic Melanoma

  • Phase I
  • Trial Category: Melanoma

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*